UPDATE: Mizuho Securities Upgrades Satsuma Pharmaceuticals (STSA) to Buy
Tweet Send to a Friend
(Updated - June 22, 2021 5:24 AM EDT)
Mizuho Securities analyst Vamil Divan upgraded Satsuma Pharmaceuticals (NASDAQ: STSA) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Mizuho Securities analyst Vamil Divan upgraded Satsuma Pharmaceuticals (NASDAQ: STSA) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
